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1. Introduction
  Anticoagulation is very effective for primary and secondary 
prevention of thromboembolic events. Warfarin sodium is 
the well known and the most widely used anticoagulant. 
Sublingual hematoma is the rare complication and can cause 
the airway obstruction. We present the case of sublingual 
hematoma secondary to usage of Warfarin therapy.
2. Case report
  A 43-year-old woman with a history of mitral valve 
replacement surgery of two years ago presented to the 
emergency department (ED) with swelling and bleeding in 
the mouth initiating 6 h ago. She has been taking warfarin 5 
mg once a day for two years. The patient’s vital signs were as 
follows: blood pressure was 149/89 mmHg, heart rate 117/min, 
respiratory rate 19/min and body temperature 36.6 曟. Physical 
examination was normal except bloody sublingual hematoma 
(Figure). Prothrombin (PT) and activated prothrombin time 
(aPTT) and International Normalized Ratio (INR=7.4) were 
prolonged. She was admitted to the hospital. The only fresh 
frozen plasma (FFP) and vitamin K were given for treatment. In 
the 24 h, symptoms and signs resolved almost completely and 
the patient showed no signs of respiratory distress at any point 
in time. She was discharged from the hospital fully recover the 
2 d later. 
3. Discussion
  Warfarin is frequently used as an oral anticoagulant in a 
variety of clinical setting, e.g. atrial fibrillation or following 
valvular heart disease1. The most common complications are 
bleeding in the genitourinary and gastrointestinal tracts, skin, 
central nervous system, nose, penis, or retroperitoneum. Major 
bleeding, which includes intracranial hemorrhage and bleeding 
leading to death or hospitalization, has been reported in 
1.2%-8.1% of patients during each year of long-term warfarin 
therapy1. However, rarely, warfarin may cause bleeding that 
compromises a patient’s airway. A sublingual hematoma like 
our patient is a rare and unexpected complication. There were 
a number of case reports in the medical literature. These cases 
vary in their severity. Our case is more benign than other 
cases. In some of reported case in the medical literature, both 
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invasive (cricothyroidotomy or tracheostomy) and noninvasive 
(orotrakeal intubation) techniques were performed for 
definitive airway stabilization[2-6]. 
  Hemorrhage and hematoma of the oral cavity can be fatal. 
Spontaneous bleeding and hematoma into the sublingual 
and submaxillary spaces can create a pseudo-Ludwig’s 
phenomenon[4]. With the expanding hematoma, tongue and 
floor of the mouth become elevated and can cause airway 
obstruction. In this situation, laryngoscopic intubation is 
impossible. Because of these reasons, early definitive airway 
stabilization should be performed with rapid sequence 
intubation (RSI). If RSI is failure, emergency cricothyroidotomy 
or tracheostomy should be performed for definitive airway 
stabilization in the emergency department. Life-threatening 
hemorrhage secondary to oral anticoagulant should be 
immediately reversed with FFP, followed by vitamin K, FFP is 
rich in active vitamin K-dependent coagulation factors and 
will reverse oral anticoagulant-induced coagulopathy in most 
patients. In general, approximately 15 mL/kg of FFP should be 
adequate to reverse any coagulopathy[7-22].
  In conclusion, warfarine induced sublingual hematoma can 
cause airway obstruction. In these patients early definitive 
airway management is crucial treatment in the emergency 
department. 
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